We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Monitoring Technology Keeps COVID-19 Vaccines Safe

By HospiMedica International staff writers
Posted on 01 Dec 2020
Image: The OneVue Sense monitors vaccine storage temperatures (Photo courtesy of Primex)
Image: The OneVue Sense monitors vaccine storage temperatures (Photo courtesy of Primex)
An automated environmental monitoring platform can help administrators prepare for the pending global rollout of COVID-19 vaccines.

The Primex (Lake Geneva, WI, USA) OneVue Sense sensor incorporates a cryogenic probe that can monitor storage units for temperatures as low as minus 200 degrees Celsius. Once paired with the OneVue Monitor automated monitoring software solution, the integrated system provides real-time alerts if vaccine storage temperatures fluctuate outside of the specified temperature range, helping maintain vaccine safety and effectiveness. The system also archives all recorded temperatures to ensure compliance.

In addition to environmental temperature monitoring, the OneVue monitoring software also provides indoor air quality data, differential pressure reading, and contact closure monitoring solutions, which can be used to monitor hospital isolation rooms and to ensure that freezer storage doors remain closed. The cloud-based software powering the OneVue system is fully customizable, enabling users to schedule reports, alerts, and messaging to suit specific needs, and to synchronize many different types of devices across a facility.

“For nearly 50 years, healthcare providers have trusted Primex to deliver proven and reliable healthcare solutions. We are proud to be part of this monumental public health effort to ensure safe, reliable, and effective COVID-19 vaccines reach the public,” said Paul Shekoski, CEO of Primex. “Any breach in temperature control can degrade a vaccine, making it lose its full potency. With the Primex OneVue platform, customers have peace of mind knowing that the vaccine will always remain at the proper temperature.”

The current leading COVID-19 vaccine candidates are expected to require extremely cold storage temperatures, with some, such as the Pfizer (New York, NY, USA) candidate, requiring storage and triage at temperatures as low as minus 70 degrees Celsius.

Related Links:
Primex
Pfizer


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical Examination & Procedure Light
Vega 80
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel

Channels